Health Care/Hospital

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023. This includes another series of global firsts and pioneering medical...

2023-11-21 14:57 1094

ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop

SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development...

2023-11-21 12:00 1150

Phyathai and Paolo Hospital Group Recognized for Corporate Excellence at the Asia Pacific Enterprise Awards 2023 Thailand

SINGAPORE, Nov. 20, 2023 /PRNewswire/ -- Phyathai and Paolo Hospital Group (Phyathai and Paolo) was honored with the Corporate Excellence Award at the Asia Pacific Enterprise Awards 2023 Thailand for its outstanding commitment to excellence throughout its 50 years of business. As a well-establish...

2023-11-21 09:54 1307

FC Mother to open first HOME healing center in Brazil - launching announcement with premiere of A.I. film tribute from Pelé to his mother

Film is first part of "Mothers of Fútbol" series, highlighting the importance of maternal well-being SANTOS, Brazil, Nov. 20, 2023 /PRNewswire/ -- FC Mother , a pioneering initiative dedicated to enhancing the well-being of our mothers, has joined forces with thePelé F...

2023-11-21 07:48 1226

Innovative Breakthrough: Taiwan-BioActive Lipid (T-BAL) Redefines the Functional Food Landscape with Lipid Nanoparticles

TAICHUNG, Nov. 21, 2023 /PRNewswire/ -- In a groundbreaking stride within the functional food domain,Taiwan's Lipid Encapsulation and Analysis Corporation has harnessed the potential of Lipid Encapsulated Technology to unveil a revolutionary product line. Introducing nano-sized spheres adept at c...

2023-11-21 06:00 1185

Concord Medical Schedules 2023 Annual Meeting of Shareholders

BEIJING, Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensi...

2023-11-21 05:00 1244

Preserving Tradition in the Digital Age: A Historic Collaboration for Digitising Bhutan's Medicinal Plants and Herbs

NEW YORK and SINGAPORE, Nov. 20, 2023 /PRNewswire/ -- In a landmark move, four eminent organisations have united under a Memorandum of Understanding (MOU) signed on17 November 2023. This alliance aims to digitise and certify Bhutan's treasured Sowa-Rigpa, the ancient Traditional Medicines know...

2023-11-20 22:00 1449

CARsgen Announces Formation of its Clinical Advisory Board

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory Board. This highly regarded pa...

2023-11-20 21:50 2369

Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime

Sofwave's Synchronous Ultrasound Parallel Beam (SUPERB™) technology significantly reduces downtime while offering outstanding results no matter the skin type. SAN ANTONIO, Nov. 20, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the non-invasive skin tightening industry and, based on i...

2023-11-20 21:30 1085

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva...

2023-11-20 21:03 1027

Viva Biotech Secures Approximately US$ 210 Million Funding

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced thatit completed a funding round, securing approximatelyUS$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transact...

2023-11-20 20:04 2322

Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging

SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...

2023-11-20 20:00 952

Prenetics Announces Third Quarter 2023 Financial Results

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter endedSeptember 30, 2023, along with recent business updates. Third Quarter 20...

2023-11-20 19:30 1914

TSI Group Joins Halma Group, Unveiling New Avenues for Growth

SUGAR LAND, Texas, Nov. 20, 2023 /PRNewswire/ -- TeDan Surgical Innovations, a leading player in the medical technology sector, is thrilled to announce its inclusion in the Halma Group. This strategic move marks the formation of the TSI Group, which is comprised of TeDan Surgical Innovations, Wes...

2023-11-20 19:00 1400

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as "MicuRx") announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...

2023-11-20 18:34 1205

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...

2023-11-20 14:39 1164

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference. HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The com...

2023-11-20 07:09 1557

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...

2023-11-18 08:00 2796

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologie...

2023-11-17 22:21 3552

Oncoclínicas has Net Profit of R$149 million (162% higher vs 3Q22) and Gross Revenue of R$1.5 billion in the third quarter

Operating Cash Generation was R$322 million, a record for the company's third quarter SÃO PAULO, Nov. 17, 2023 /PRNewswire/ -- Oncoclínicas & Co. (B3: ONCO3) reported a 23.4% increase in its gross revenue in the third quarter of 2023, reachingR$1.5 billion, another record for the company. The pe...

2023-11-17 22:10 1992
1 ... 63646566676869 ... 807